Hyperandrogenism
Mostrando 1-12 de 29 artigos, teses e dissertações.
-
1. Does asporin have a role in polycystic ovary syndrome? A pilot study
SUMMARY OBJECTIVE: Asporin is secreted by theca cells in the mouse ovaries and is an effective marker at the gonadotropin-independent stage in secondary follicle development. It has an inhibitory effect on transforming growth factor beta and bone morphogenic proteins, which are involved in androgenesis process. Our aim was to compare serum asporin levels of
Revista da Associação Médica Brasileira. Publicado em: 2022
-
2. Pediatric androgenetic alopecia: a retrospective review of clinical characteristics, hormonal assays and metabolic syndrome risk factors in 23 patients
Abstract Background Androgenetic alopecia in the pediatric population is rarely discussed in the literature. Although the prevalence of the metabolic syndrome is increased in patients with early-onset androgenetic alopecia, the presence of metabolic syndrome risk factors in pediatric androgenetic alopecia is unknown. Objective To evaluate the demographics,
Anais Brasileiros de Dermatologia. Publicado em: 2022
-
3. Differences in hormonal levels between heterozygous CYP21A2 pathogenic variant carriers, non-carriers, and females with non-classic congenital hyperplasia
ABSTRACT Objective: CYP21A2 mutation heterozygote carriers seem to have an increased risk of hyperandrogenism. However, the clinical relevance of the heterozygote carrier status and the reliability of hormonal testing in discriminating a carrier from a non-carrier are puzzling questions. We aimed to characterize a population of Portuguese females suspected
Archives of Endocrinology and Metabolism. Publicado em: 2022
-
4. Polymorphisms rs2010963 and rs833061 of the VEGF gene in polycystic ovary syndrome
SUMMARY OBJECTIVE: The polycystic ovary syndrome is the most common endocrine disorder, characterized by the dysregulation of ovarian angiogenesis. This alteration can be related to changes in the activities of the vascular endothelial growth factor (VEGF) gene. Single-nucleotide polymorphisms have been observed in the promoter, intronic, and untranslated r
Revista da Associação Médica Brasileira. Publicado em: 2022
-
5. New Criteria for the Clinical Diagnosis of Hyperandrogenism in Polycystic Ovarian Syndrome and the Risk of Overdiagnosis
Rev. Bras. Ginecol. Obstet.. Publicado em: 22/07/2019
-
6. The Prevalence of Metabolic Syndrome in the Different Phenotypes of Polycystic Ovarian Syndrome
Resumo Objetivo Avaliar a prevalência da síndromemetabólica nos fenótipos da síndrome do ovário policístico. Métodos Trata-se deum estudo transversal envolvendo 111 mulheres comidade entre 18 e39 anos com diagnóstico de síndrome do ovário policístico, segundo os critérios de Roterdã, e agrupadas em quatro fenótipos: A: Disfunção ovulató
Rev. Bras. Ginecol. Obstet.. Publicado em: 15/04/2019
-
7. Sleep disorders in polycystic ovary syndrome: influence of obesity and hyperandrogenism
RESUMO OBJETIVO: Este estudo objetivou avaliar o sono de mulheres com síndrome do ovário policístico, com e sem hiperandrogenismo, em comparação com um grupo controle saudável, e estudar os efeitos do hiperandrogenismo e da obesidade nos parâmetros do sono. MÉTODOS: Um total de 44 voluntárias foram recrutadas para participar do estudo. Os parâmet
Rev. Assoc. Med. Bras.. Publicado em: 11/04/2019
-
8. Infantile generalized hypertrichosis caused by topical minoxidil
Abstract Rare cases of hypertrichosis have been associated with topically applied minoxidil. We present the first reported case in the Brazilian literature of generalized hypertrichosis affecting a 5-year-old child, following use of minoxidil 5%, 20 drops a day, for hair loss. The laboratory investigation excluded hyperandrogenism and thyroid dysfunction. To
An. Bras. Dermatol.. Publicado em: 2016-02
-
9. Marcadores do sistema hemostático e sua associação com parâmetros clínicos e laboratoriais em mulheres com síndrome dos ovários policísticos = : Markers of the hemostatic system and their association with clinical and laboratory parameters in women with polycystic ovary syndrome / Markers of the hemostatic system and their association with clinical and laboratory parameters in women with polycystic ovary syndrome
Introduction: Few studies have been conducted on hemostatic disorders in polycystic ovary syndrome (PCOS). In women with PCOS, thromboembolic risk factors such as obesity, hyperandrogenism and insulin resistance are often present, indirectly suggesting a greater probability of coagulation disorders. Objective: To evaluate some markers of the hemostatic syste
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 03/10/2012
-
10. ANÁLISE DOS CRITÉRIOS CLÍNICOS DE DIAGNÓSTICO DA SÍNDROME DOS OVÁRIOS POLICÍSTICOS SEGUNDO OS CONSENSOS / ANALYSIS OF THE CLINICAL CRITERIA OF DIAGNOSTIC OF POLYCYSTIC OVARY SYNDROME ACCORDING TO CONSENSUS
Polycystic Ovary Syndrome (PCOS) is diagnosed by consensus of the National Institute of Health (NIH- USA, 1990), Rotterdam (Netherlands, 2003) and Androgen Excess Syndrome - PCOS (AES-PCOS, 2006). It is important to recognize the clinical characteristics of PCOS patients in Maranhão to submit a profile Objectives: To evaluate the prevalence of the PCOS acco
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 18/06/2012
-
11. Dificuldades e armadilhas no diagnóstico da síndrome dos ovários policísticos
A síndrome dos ovários policísticos é uma das endocrinopatias mais comuns, afetando aproximadamente 7% das mulheres na idade reprodutiva. Embora tenha sido descrita em 1935, somente em 1990 foi elaborado o primeiro consenso com relação ao seu diagnóstico. Hoje, a síndrome é considerada também um fator de risco cardiovascular, com uma alta prevalên
Arquivos Brasileiros de Endocrinologia & Metabologia. Publicado em: 2011-02
-
12. Assessment of symptoms of urinary incontinence in women with polycystic ovary syndrome
OBJECTIVES: The pelvic floor muscles are sensitive to androgens, and due to hyperandrogenism, women with polycystic ovary syndrome can have increased mass in these muscles compared to controls. The aim of this study is to compare reports of urine leakage and quality of life between women with and without polycystic ovary syndrome. METHODS: One hundred thirte
Clinics. Publicado em: 2011